Co-Diagnostics, Inc.

CODXNasdaqCIK 1692415HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 138 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Co-Diagnostics, Inc., Reports and events
Filed	Form	What it is	Accession number
2024-06-1407:35 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001493152-24-023796
2024-05-0916:05 ET	10-Q	Quarterly reportPeriod 2024-03-31	0001493152-24-018424
2024-05-0916:01 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-24-018418
2024-03-1516:05 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001493152-24-010089
2024-03-1416:05 ET	10-K	Annual reportPeriod 2023-12-31	0001493152-24-009955
2024-03-1416:01 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-24-009950
2023-11-0916:05 ET	10-Q	Quarterly reportPeriod 2023-09-30	0001493152-23-040050
2023-11-0916:01 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-23-040049
2023-08-3116:05 ET	8-K	5.07 Shareholder vote results	0001493152-23-031051
2023-08-1016:05 ET	10-Q	Quarterly reportPeriod 2023-06-30	0001493152-23-027538
2023-08-1016:03 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-23-027534
2023-07-2006:10 ET	DEF 14A	Proxy statementPeriod 2023-07-20	0001493152-23-024982
2023-05-1616:30 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001493152-23-017799
2023-05-1116:55 ET	10-Q	Quarterly reportPeriod 2023-03-31	0001493152-23-016425
2023-05-1116:03 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-23-016376
2023-04-0517:01 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001493152-23-011062
2023-03-1616:30 ET	10-K	Annual reportPeriod 2022-12-31	0001493152-23-007925
2023-03-1616:05 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-23-007900
2022-11-1016:11 ET	10-Q	Quarterly reportPeriod 2022-09-30	0001493152-22-031350
2022-11-1016:04 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-22-031335
2022-09-0216:30 ET	8-K	5.07 Shareholder vote results	0001493152-22-024979
2022-08-1116:06 ET	10-Q	Quarterly reportPeriod 2022-06-30	0001493152-22-022072
2022-08-1116:02 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-22-022067
2022-07-2017:00 ET	DEF 14A	Proxy statementPeriod 2022-07-20	0001493152-22-019947
2022-06-1616:30 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001493152-22-016975
2022-05-1216:05 ET	10-Q	Quarterly reportPeriod 2022-03-31	0001493152-22-013020
2022-05-1216:02 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-22-013017
2022-04-0117:00 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001493152-22-008865
2022-03-2416:08 ET	10-K	Annual reportPeriod 2021-12-31	0001493152-22-007662
2022-03-2416:02 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-22-007660
2022-03-1509:40 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events	0001493152-22-006811
2021-12-2311:40 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-032360
2021-11-1206:10 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001493152-21-027937
2021-11-1206:05 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-027932
2021-08-1216:06 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001493152-21-019503
2021-08-1216:01 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-019494
2021-08-0515:15 ET	8-K	5.07 Shareholder vote results	0001493152-21-018709
2021-07-0917:35 ET	8-K	5.02 Departure or appointment of officers or directors	0001493152-21-016480
2021-06-2213:20 ET	DEF 14A	Proxy statementPeriod 2021-06-22	0001493152-21-014976
2021-05-1316:10 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-011289
2021-05-1316:06 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001493152-21-011279
2021-03-2617:38 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-006840
2021-03-2516:16 ET	10-K	Annual reportPeriod 2020-12-31	0001493152-21-006810
2021-02-2207:00 ET	8-K	5.02 Departure or appointment of officers or directors	0001493152-21-004459
2021-01-0609:30 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-000275
2020-12-1712:03 ET	8-K	5.07 Shareholder vote results	0001493152-20-023820
2020-11-1616:05 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001493152-20-021670
2020-11-1616:01 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-021666
2020-11-0311:56 ET	DEF 14A	Proxy statementPeriod 2020-11-03	0001493152-20-020363
2020-11-0307:00 ET	10-Q/A	Quarterly report, amendedPeriod 2020-06-30	0001493152-20-020357

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:01 ET. Listed shows no prices and gives no investment advice.